Minerva Neurosciences, Inc.
At Close: 4:00 PM
NERV Stock Price Graph
NERV Stock Price Today
Minerva Neurosciences, Inc. (NERV) stock rallied over 10.02% intraday to trade at $5.6 a share on NASDAQ. The stock opened with a loss of -12.13% at $4.49 and touched an intraday high of $4.69, rising 9.59% against the last close of $5.11. The Minerva Neurosciences, Inc. in stock market went to a low of $4.27 during the session.
NERV Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
NERV Stock Price History Chart
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Frequently Asked Questions
What is the current Minerva Neurosciences, Inc. (NERV) stock price?
Minerva Neurosciences, Inc. (NASDAQ: NERV) stock price is $5.60 in the last trading session. During the trading session, NERV stock reached the peak price of $4.69 while $4.27 was the lowest point it dropped to. The percentage change in NERV stock occurred in the recent session was 10.02% while the dollar amount for the price change in NERV stock was $0.51.
NERV's industry and sector of operation?
The NASDAQ listed NERV is part of Biotechnology industry that operates in the broader Healthcare sector. Minerva Neurosciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.
Who are the executives of NERV?
Dr. Remy Luthringer Ph.D.
Executive Chairman & Chief Executive Officer
Mr. William B. Boni
Vice President of Investor Relations & Corporation Communications
Mr. Frederick W. Ahlholm CPA, CPA
Senior Vice President, Chief Financial Officer & Sec.
Mr. Joseph Reilly
Senior Vice President & Chief Operating Officer
How NERV did perform over past 52-week?
NERV's closing price is 2.66% higher than its 52-week low of $1.26 where as its distance from 52-week high of $13.22 is -0.70%.
How many employees does NERV have?
Number of NERV employees currently stands at N/A. NERV operates from 1601 Trapelo Road, Waltham, MA 02451, US.
Link for NERV official website?
Official Website of NERV is: https://www.minervaneurosciences.com
How do I contact NERV?
How many shares of NERV are traded daily?
NERV stock volume for the day was 36058.00 shares. The average number of NERV shares traded daily for last 3 months was 18.7 Thousands.
What is the market cap of NERV currently?
The market value of NERV currently stands at $39.14 Million with its latest stock price at $5.60 and N/A of its shares outstanding.